Evidence map›Paper›PMID 36465918›Full record

ArticleFrontiers in medicine2022

Case report: Antiplatelet therapy on metastatic paraganglioma-associated cutaneous vascular disease and literature review.

Yinjie Gao, Yunying Cui, Zhonghui Hu, Yu Wang, Tianyi Li, Yuehua Liu, Anli Tong

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yinjie GaoNHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
Yunying CuiNHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
Zhonghui HuDepartment of Dermatology, Peking Union Medical College Hospital, Beijing, China.
Yu WangNHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
Tianyi LiNHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
Yuehua LiuDepartment of Dermatology, Peking Union Medical College Hospital, Beijing, China.
Anli TongNHC Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Beijing, China.
Peking Union Medical College Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Context: Tumor-associated cutaneous vascular disorder induced by PPGL was extremely rare, and the cutaneous manifestations could disappear after removal of the tumors. However, the definite pathological diagnosis and the potential mechanism remained unidentified. We presented a severe cutaneous vascular lesion manifested as diffuse erythema with ulceration and necrosis over the limbs in a female patient with metastatic paraganglioma. Skin biopsy was performed on her for defining the pathological diagnosis and potential mechanism. The patient was diagnosed as vascular disease according to the obvious angioectasia in dermis on cutaneous pathology, which might be caused by PPGL-induced hypercoagulability. We used the antiplatelet therapy with aspirin to treat the PPGL-associated cutaneous vascular disease for the first time, and the cutaneous lesions were relieved and healed gradually, further supporting the diagnosis of vascular disease. Conclusion: For metastatic PPGL patients like the case we reported, the definite diagnosis by skin biopsy and the early antiplatelet therapy might be effective to the cutaneous lesions caused by the hypercoagulable state of PPGL.

Indexed as

antiplatelet therapydiffuse erythemahypercoagulabilitypheochromocytoma/paragangliomatumor-associated cutaneous vascular disorders

Identifiers

PMID36465918
PMCPMC9713006
OpenAlexW4309610046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.